Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXYF3H
|
||||
| Drug Name |
(2E)-4-(dimethylamino)-N-[7-ethoxy-4-({4-[(3-methylbenzyl)oxy]-3,6-dioxocyclohexa-1,4-dien-1-yl}amino)quinazolin-6-yl]but-2-enamide
|
||||
| Synonyms |
CHEMBL241919
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C30H31N5O5
|
||||
| Canonical SMILES |
CCOc1cc2ncnc(NC3=CC(=O)C(=CC3=O)OCc4cccc(C)c4)c2cc1NC(=O)\\C=C\\CN(C)C
|
||||
| InChI |
InChI=1S/C30H31N5O5/c1-5-39-27-15-22-21(13-24(27)33-29(38)10-7-11-35(3)4)30(32-18-31-22)34-23-14-26(37)28(16-25(23)36)40-17-20-9-6-8-19(2)12-20/h6-10,12-16,18H,5,11,17H2,1-4H3,(H,33,38)(H,31,32,34)/b10-7+
|
||||
| InChIKey |
FWQHTPQAWDKGBW-JXMROGBWSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Epidermal growth factor receptor III | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathway | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.